J&J to acquire heart devicemaker for $13B

Johnson & Johnson has reached a definitive agreement to acquire the cardiovascular medical device company Shockwave Medical, the drugmaker said April 5.  

Under the agreement, J&J will acquire Shockwave for $335.00 per share in cash, which represents approximately $13.1 billion. Both companies' board of directors have approved the transaction. 

The acquisition will expand J&J's reach in the heart device market. The company acquired Abiomed in 2022 for $16.6 billion and Laminar in late 2023 for $400 million, according to The Wall Street Journal. 

The deal is expected to close by mid-2024. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like